Middle East Journal of Rehabilitation and Health

Published by: Kowsar

Early Direct Costs of Diagnostic and Therapeutic Services for Patients with Cancer: A Descriptive Study in Semnan, Iran, 2011 - 2014

Majid Mirmohammadkhani 1 , Farahnaz Ghahremanfard 2 , * , Khadije Tayyebi 3 and Heshmat Beigom Ghadamgahi 4
Authors Information
1 Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran
2 Department of Internal Medicine, Kowsar Hospital, Semnan University of Medical Sciences, Semnan, Iran
3 Semnan University of Medical Sciences, Semnan, Iran
4 Iran Health Insurance Organization, Tehran, Iran
Article information
  • Middle East Journal of Rehabilitation and Health: 6 (1); e55457
  • Published Online: January 23, 2019
  • Article Type: Research Article
  • Received: June 18, 2017
  • Revised: October 6, 2018
  • Accepted: December 18, 2018
  • DOI: 10.5812/mejrh.55457

To Cite: Mirmohammadkhani M, Ghahremanfard F, Tayyebi K, Ghadamgahi H B . Early Direct Costs of Diagnostic and Therapeutic Services for Patients with Cancer: A Descriptive Study in Semnan, Iran, 2011 - 2014, Middle East J Rehabil Health Stud. Online ahead of Print ; 6(1):e55457. doi: 10.5812/mejrh.55457.

Abstract
Copyright © 2019, Middle East Journal of Rehabilitation and Health Studies. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: Priorities for prevention. Carcinogenesis. 2010;31(1):100-10. doi: 10.1093/carcin/bgp263. [PubMed: 19934210]. [PubMed Central: PMC2802672].
  • 2. Kanavos P. The rising burden of cancer in the developing world. Ann Oncol. 2006;17 Suppl 8:viii15-23. doi: 10.1093/annonc/mdl983. [PubMed: 16801335].
  • 3. Azzani M, Roslani AC, Su TT. The perceived cancer-related financial hardship among patients and their families: a systematic review. Support Care Cancer. 2015;23(3):889-98. doi: 10.1007/s00520-014-2474-y. [PubMed: 25337681].
  • 4. Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: Economic cost and quality of life. Annu Rev Public Health. 2001;22:91-113. doi: 10.1146/annurev.publhealth.22.1.91. [PubMed: 11274513].
  • 5. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117-28. doi: 10.1093/jnci/djq495. [PubMed: 21228314]. [PubMed Central: PMC3107566].
  • 6. Carter D. New global survey shows an increasing cancer burden. Am J Nurs. 2014;114(3):17. doi: 10.1097/01.NAJ.0000444482.41467.3a. [PubMed: 24572524].
  • 7. Chalkidou K, Marquez P, Dhillon PK, Teerawattananon Y, Anothaisintawee T, Gadelha CA, et al. Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. Lancet Oncol. 2014;15(3):e119-31. doi: 10.1016/S1470-2045(13)70547-3. [PubMed: 24534293].
  • 8. Traebert J, Schneider IJ, Colussi CF, de Lacerda JT. Burden of disease due to cancer in a Southern Brazilian state. Cancer Epidemiol. 2013;37(6):788-92. doi: 10.1016/j.canep.2013.08.007. [PubMed: 24035552].
  • 9. Stefan DC, Elzawawy AM, Khaled HM, Ntaganda F, Asiimwe A, Addai BW, et al. Developing cancer control plans in Africa: Examples from five countries. Lancet Oncol. 2013;14(4):e189-95. doi: 10.1016/S1470-2045(13)70100-1. [PubMed: 23561751].
  • 10. Are C, Rajaram S, Are M, Raj H, Anderson BO, Chaluvarya Swamy R, et al. A review of global cancer burden: Trends, challenges, strategies, and a role for surgeons. J Surg Oncol. 2013;107(2):221-6. doi: 10.1002/jso.23248. [PubMed: 22926725].
  • 11. Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100(12):888-97. doi: 10.1093/jnci/djn175. [PubMed: 18544740]. [PubMed Central: PMC3298963].
  • 12. Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: Estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2006-14. doi: 10.1158/1055-9965.EPI-11-0650. [PubMed: 21980008]. [PubMed Central: PMC3191884].
  • 13. Yabroff KR, Warren JL, Brown ML. Costs of cancer care in the USA: A descriptive review. Nat Clin Pract Oncol. 2007;4(11):643-56. doi: 10.1038/ncponc0978. [PubMed: 17965642].
  • 14. Emami MH, Fatemi AM, Farajzadegan Z, MovahedAbtahi SM. [Epidemiology of colorectal cancer in Isfahan province]. Govaresh J. 2005;100:134-9. Persian.
  • 15. Pahlavan PS, Jensen K. A short impact of epidemiological features of colorectal cancer in Iran. Tumori. 2005;91(4):291-4. [PubMed: 16277091].
  • 16. Shafayan B, Keyhani M. Epidemiological evaluation of colorectal cancer. Acta Media lranica. 2003;41:156-60.
  • 17. Saberi-Firoozi M, Kamali D, Yousefi M, Mehrabani D, Khademolhosseini F, Heydari S, et al. Clinical characteristics of colorectal cancer in Southern Iran, 2005. Iran Red Crescent Med J. 2007;9(4):209-11.
  • 18. Pahlavan PS, Kanthan R. The epidemiology and clinical findings of colorectal cancer in Iran. J Gastrointestin Liver Dis. 2006;15(1):15-9. [PubMed: 16680227].
  • 19. Kalavi B. Colorectal cancer and its epidemiological aspects in Iran (2004). Turk J Gastroenterol. 2005;16(4):248-9. [PubMed: 16547861].
  • 20. Ferro SA, Myer BS, Wolff DA, Poniewierski MS, Culakova E, Cosler LE, et al. Variation in the cost of medications for the treatment of colorectal cancer. Am J Manag Care. 2008;14(11):717-25. [PubMed: 18999906].
  • 21. Karimi Zarchi AA, Saadat AR, Jalalian HR, Esmaeili M. [Epidemiology and survival analysis of colorectal cancer and its related factors]. Trauma Mon. 2011;2010(04, Winter):239-43. Persian.
  • 22. Emami SMH, Fatemi AM, Farajzadegan Z, Movahed-Abtahi SM. [Epidemiology of colorectal cancer in Isfahan province]. Govaresh. 2005;10(3):134-9. Persian.
  • 23. Sohrab Pour AA. The cancer in developing countries. New Med. 2012;13:660.
  • 24. Davari M, Maracy MR, Emami MH, Taheri D, Aslani A, Givi M, et al. The direct medical costs of colorectal cancer in Iran; analyzing the patient's level data from a cancer specific hospital in Isfahan. Int J Prev Med. 2012;3(12):887-92. [PubMed: 23272289]. [PubMed Central: PMC3530308].
  • 25. Adami HO, Hunter DJ, Trichopoulos D. Text book of cancer epidemiology. USA: Oxford University Press; 2002.
  • 26. Nikfarjam Z, Massoudi T, Salehi M, Salehi M, Khoshroo F. Demographic survey of four thousand patients with 10 common cancers in North Eastern Iran over the past three decades. Asian Pac J Cancer Prev. 2014;15(23):10193-8. [PubMed: 25556447].
  • 27. Dehkordi ZF, Tazhibi M, Babazade S. Application of joinpoint regression in determining breast cancer incidence rate change points by age and tumor characteristics in women aged 30-69 (years) and in Isfahan city from 2001 to 2010. J Educ Health Promot. 2014;3:115. doi: 10.4103/2277-9531.145917. [PubMed: 25540788]. [PubMed Central: PMC4275607].
  • 28. Parkin D, Whelan S, Ferlay J. Cancer incidence in five continents. IARC (International Agency for Research Cancer) Publication; 2002.
  • 29. Hadi N, Sadeghi-Hassanabadi A, Talei AR, Arasteh MM, Kazerooni T. Assessment of a breast cancer screening programme in Shiraz, Islamic Republic of Iran. East Mediterr Health J. 2002;8(2-3):386-92. [PubMed: 15339128].
  • 30. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: Results of a multi-center study. Asian Pac J Cancer Prev. 2004;5(1):24-7. [PubMed: 15075000].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments